Holen Sie sich die Stockscreener-App
9.85
0.41%
0.04
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
Jump Financial LLC Raises Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
How Amicus Therapeutics Inc. (FOLD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
3,235,538 Shares in Amicus Therapeutics, Inc. $FOLD Bought by Norges Bank - MarketBeat
Amicus Therapeutics, Inc. $FOLD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Can Galafold continue to drive Amicus' top line in 2026? - MSN
Amicus Therapeutics, Inc. $FOLD Shares Sold by Prudential Financial Inc. - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock - Finviz
Can Galafold Continue to Drive Amicus' Top Line in 2026? - Eastern Progress
Schroder Investment Management Group Purchases 649,177 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
What is the fair value estimate for Amicus Therapeutics Inc. (AM6) stock in 2025Quarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares - MarketBeat
Is Amicus Therapeutics Inc. (AM6) stock nearing a technical breakout2025 Analyst Calls & Consistent Profit Trade Alerts - Newser
BMY Gains on News of Continuation of Alzheimer's Disease Study - Finviz
Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
How Amicus Therapeutics Inc. (AM6) stock performs in volatility spikes2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Pompe Disease Treatment Market is expected to reach US$ 4.06 - openPR.com
Amicus Therapeutics CEO Sells Shares - TradingView
What analysts say about Amicus Therapeutics Inc stockStock Valuation Metrics & We Spotted the Next Tesla – See Inside - earlytimes.in
Will Amicus Therapeutics Inc. (AM6) stock benefit from mergersLong Setup & Safe Capital Growth Stock Tips - Newser
Capital Fund Management S.A. Has $4.37 Million Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Will Amicus Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Highlights & Reliable Entry Point Trade Alerts - Newser
Why Amicus Therapeutics Inc. (AM6) stock could break out in 2025Recession Risk & Daily Profit Maximizing Tips - Newser
Amicus Therapeutics, Inc. $FOLD Stock Position Raised by Virtus Investment Advisers LLC - MarketBeat
Creative Planning Purchases 180,652 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Advantage Alpha Capital Partners LP Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month - Yahoo Finance
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook - Yahoo Finance
Intech Investment Management LLC Sells 47,907 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat
Geode Capital Management LLC Sells 57,278 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Envestnet Asset Management Inc. Has $368,000 Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
David Michael Clark Sells 25,643 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock - MarketBeat
Insider Selling: Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares of Stock - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires 95,565 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Insider Ellen Rosenberg Sells 23,621 Shares - MarketBeat
Insider Sell Alert: David Clark Sells 25,643 Shares of Amicus Th - GuruFocus
Amicus Therapeutics chief legal officer sells $958k in stock By Investing.com - Investing.com Canada
Amicus Therapeutics chief people officer sells $258,932 in stock By Investing.com - Investing.com Canada
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet - Finviz
Officer Clark Sells 25,643 ($258.9K) Of Amicus Therapeutics Inc [FOLD] - TradingView
CEO Campbell Sells 14,587 ($146.5K) Of Amicus Therapeutics Inc [FOLD] - TradingView
Officer Rosenberg Sells 95,621 ($958.5K) Of Amicus Therapeutics Inc [FOLD] - TradingView
Amicus Therapeutics Executives Sell Shares - TradingView
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month HighWhat's Next? - MarketBeat
AXQ Capital LP Makes New $290,000 Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Officer Castelli Files To Sell 76,158 Of Amicus Therapeutics Inc [FOLD] - TradingView
Amicus Therapeutics stock hits 52-week high at $10.36 By Investing.com - Investing.com Nigeria
Amicus Therapeutics stock hits 52-week high at $10.36 - Investing.com
Amicus Therapeutics Inc AM6 Stock Analysis and ForecastIndustrial Stocks Review & Rapid Profit Growth - earlytimes.in
Primecap Management Co. CA Sells 123,400 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
First Week of July 2026 Options Trading For Amicus Therapeutics (FOLD) - Nasdaq
Is Amicus Therapeutics Inc. stock supported by strong fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Vise Technologies Inc. Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Is Amicus Therapeutics Inc. stock attractive for growth ETFs2025 Price Momentum & Fast Momentum Entry Tips - newser.com
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):